Fibrinolytic therapy in a patient with Denver peritoneovenous shunt occlusion.
Urokinase thrombolytic therapy was used on three separate occasions to lyse thrombosed Denver peritoneovenous shunts in a 51-year-old woman. Shunt patency was preserved over a 2-year period, with a fatal complication following the third procedure. The authors suggest that thrombolytic therapy might be a viable alternative to immediate surgical revision in patients with failed Denver shunts.
Halin
N J
NJ
Department of Radiology, Metropolitan Hospital-Central Division, Philadelphia.
Halin
L M
LM
D005260:Female; D006801:Humans; D008875:Middle Aged; D010536:Peritoneovenous Shunt; D015912:Thrombolytic Therapy / Q000379:methods*; D013927:Thrombosis / Q000188:drug therapy*; D014568:Urokinase-Type Plasminogen Activator / Q000627:therapeutic use*
D014568:Urokinase-Type Plasminogen Activator